OMICRON, the 15th letter of the Greek alphabet has been
drafted by the World Health Organization
as the name for the new COVID-19 variant, technically known as the B.1.1.529
variant. The Omicron variant is a reminder of what scientists and medical
experts have been saying for months: COVID-19 will thrive as long as vast
numbers of the global population are not vaccinated.
Scientists say that Omicron is the weirdest creature they have
ever encountered with 30 unruly swarm of mutations scattered on three major
prongs of the spike protein that is essential to the virus ability to infect
cells, a first of its kind with so many
mutations gathered in "one package." Even though some of these
mutations are recognizable, many of them
are new and utterly enigmatic.
That said, scientists do not want to get ahead of the facts: no
one knows exactly yet how this variant behaves in real-world situations. However,
should they find a high degree of immune-evasiveness, vaccine makers will have
to revise their formulas, something
already in the works at preliminary stage.
Is it really as bad as it looks at first glance ? Earlier variants including Alpha and Delta
had mutated in ways that enhanced their transmissibility. The latest preliminary study showed that the Omicron
variant is likely to have picked up genetic material from another virus that
causes the common cold in humans. This suggests that the Omicron variant could
have greater transmissibility but lower virulence than other variants of the
coronavirus. However, scientists have
long feared the possibility that the coronavirus would evolve to become a more
slippery, elusive pathogen—evading, even
if only partially, the first lines of
defense from the immune system, including neutralizing antibodies.
When a virus infects a human, the virus attaches itself to the
human cells and once it is inside , it makes copies of its RNA which helps it
spread. If there's an error in the copying process, the RNA gets altered or
changed. Those alterations are called mutations. The mutations change one amino acid to another in a way that can alter
the structure or chemistry of the protein and prevent antibodies from binding
as they normally would. When a virus
replicates, the end copy has differences in DNA and RNA. Mutations arise from those differences. A "collection" of these mutations becomes a variant.
So where do we go from here? Many elements of the Omicron are
still unknown. Scientists are literally working day and night to find out more.
However, their advice is: vaccination is still the key. Vaccines work by
training the immune system against the coronavirus spike protein. Had it not
been for the vaccines that were jabbed into our arms, many more millions would
have died.
There are other elements of the immune system such as
"killer" T cells. These are immune cells that recognize and attack
virus-infected cells and educate anti-body producing B cells about the viral
risk they are facing. Scientists believe that the T cells can see the differences
between variants, and that the T cell repertoire is much more impervious to it,
guaranteeing some protection. Vaccinated individuals are roughly 9x less likely
to die if they become infected with the Omicron.
Although it is difficult to predict from a virus' mutations how
it will act, many scientists say they think omicron may ultimately require a
revised vaccine. The major vaccine
companies are at work doing that. Pfizer
and BioNTech have announced that adapting their vaccine will take six weeks and
that the first batches could be shipped within 100 days.
Unless more of the world population becomes vaccinated, the
frenzy of worry is likely to continue to repeat. Health experts say that "if
we don't develop systems to immunize the whole world in four months, instead of
four years, we are not going to be successful against these kind of pandemic
threats." Viruses adapt and they
change, and unless we develop generalized global immunity more readily, we will
always be in the mercy of one pandemic after another. It is a colossal task
that requires a herculean effort and cooperation by the international
community.
Noralyn Onto Dudt is a
resident of North Bethesda, Maryland near the National Institutes of Health.
Comments
Post a Comment